- Home
- GNS vs WHWK Comparison
GNS vs WHWK Comparison
Compare GNS & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- WHWK
- Stock Information
- Founded
- GNS 2002
- WHWK 2007
- Country
- GNS Singapore
- WHWK United States
- Employees
- GNS N/A
- WHWK N/A
- Industry
- GNS Other Consumer Services
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- GNS Real Estate
- WHWK Health Care
- Exchange
- GNS Nasdaq
- WHWK Nasdaq
- Market Cap
- GNS 81.8M
- WHWK 95.2M
- IPO Year
- GNS 2022
- WHWK N/A
- Fundamental
- Price
- GNS $0.88
- WHWK $2.20
- Analyst Decision
- GNS
- WHWK
- Analyst Count
- GNS 0
- WHWK 0
- Target Price
- GNS N/A
- WHWK N/A
- AVG Volume (30 Days)
- GNS 1.1M
- WHWK 5.2M
- Earning Date
- GNS 09-23-2025
- WHWK 11-06-2025
- Dividend Yield
- GNS N/A
- WHWK N/A
- EPS Growth
- GNS N/A
- WHWK N/A
- EPS
- GNS N/A
- WHWK N/A
- Revenue
- GNS $5,749,894.00
- WHWK $14,384,000.00
- Revenue This Year
- GNS $82.78
- WHWK N/A
- Revenue Next Year
- GNS $85.90
- WHWK N/A
- P/E Ratio
- GNS N/A
- WHWK N/A
- Revenue Growth
- GNS N/A
- WHWK N/A
- 52 Week Low
- GNS $0.21
- WHWK $1.39
- 52 Week High
- GNS $1.92
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- GNS 55.59
- WHWK 49.46
- Support Level
- GNS $0.69
- WHWK $2.01
- Resistance Level
- GNS $0.78
- WHWK $2.30
- Average True Range (ATR)
- GNS 0.06
- WHWK 0.18
- MACD
- GNS 0.01
- WHWK -0.04
- Stochastic Oscillator
- GNS 82.84
- WHWK 35.58
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.